Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
43
OSUR Quote, Financials, Valuation and Earnings
Last price:
$3.18
Seasonality move
:
13.64%
Day range:
$2.51 - $3.14
52-week range:
$2.08 - $4.22
Dividend yield:
0%
P/E ratio:
26.67x
P/S ratio:
1.97x
P/B ratio:
0.61x
Volume:
1M
Avg. volume:
489K
1-year change:
0.65%
Market cap:
$220.9M
Revenue:
$115M
EPS (TTM):
-$0.94
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$26.4M | -$0.15 | -7.72% | -34.16% | $6.00 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.2M | $0.04 | 17.11% | -88.21% | $24.62 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.3% | 75.74% | $104.75 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$3.08 | $6.00 | $220.9M | 26.67x | $0.00 | 0% | 1.97x |
|
ABT
Abbott Laboratories
|
$116.26 | $133.39 | $202.2B | 31.28x | $0.63 | 2.06% | 4.59x |
|
ARAY
Accuray, Inc.
|
$0.58 | $2.53 | $69.5M | 149.00x | $0.00 | 0% | 0.15x |
|
ATEC
Alphatec Holdings, Inc.
|
$14.01 | $24.62 | $2.1B | -- | $0.00 | 0% | 2.75x |
|
BSX
Boston Scientific Corp.
|
$75.75 | $104.75 | $112.4B | 39.06x | $0.00 | 0% | 5.64x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.32 | $5.50 | $44.6M | -- | $0.00 | 0% | 5.20x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
-- | 0.712 | -- | 5.57x |
|
ABT
Abbott Laboratories
|
21.33% | 0.141 | 6.97% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.394 | 177.87% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.3% | 1.400 | 18.93% | 1.24x |
|
BSX
Boston Scientific Corp.
|
33.07% | 0.200 | 8.45% | 0.94x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
$11M | -$16.9M | -17.66% | -18.18% | -62.97% | -$9.9M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATEC
Alphatec Holdings, Inc.
|
$130.4M | -$5.4M | -23.65% | -1092.5% | -2.52% | $5.7M |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
OraSure Technologies, Inc. vs. Competitors
-
Which has Higher Returns OSUR or ABT?
Abbott Laboratories has a net margin of -72.06% compared to OraSure Technologies, Inc.'s net margin of 15.71%. OraSure Technologies, Inc.'s return on equity of -18.18% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.40.98% -$0.27 $340.8M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About OSUR or ABT?
OraSure Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 94.81%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 14.73%. Given that OraSure Technologies, Inc. has higher upside potential than Abbott Laboratories, analysts believe OraSure Technologies, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 ABTAbbott Laboratories16 7 0 -
Is OSUR or ABT More Risky?
OraSure Technologies, Inc. has a beta of 0.869, which suggesting that the stock is 13.058% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock OSUR or ABT?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.06% to investors and pays a quarterly dividend of $0.63 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios OSUR or ABT?
OraSure Technologies, Inc. quarterly revenues are $26.8M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. OraSure Technologies, Inc.'s net income of -$19.3M is lower than Abbott Laboratories's net income of $1.8B. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Abbott Laboratories's PE ratio is 31.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.97x versus 4.59x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.97x 26.67x $26.8M -$19.3M ABTAbbott Laboratories4.59x 31.28x $11.5B $1.8B
-
Which has Higher Returns OSUR or ARAY?
Accuray, Inc. has a net margin of -72.06% compared to OraSure Technologies, Inc.'s net margin of -13.47%. OraSure Technologies, Inc.'s return on equity of -18.18% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.40.98% -$0.27 $340.8M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About OSUR or ARAY?
OraSure Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 94.81%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 331.7%. Given that Accuray, Inc. has higher upside potential than OraSure Technologies, Inc., analysts believe Accuray, Inc. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 ARAYAccuray, Inc.2 0 0 -
Is OSUR or ARAY More Risky?
OraSure Technologies, Inc. has a beta of 0.869, which suggesting that the stock is 13.058% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.151, suggesting its more volatile than the S&P 500 by 15.124%.
-
Which is a Better Dividend Stock OSUR or ARAY?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or ARAY?
OraSure Technologies, Inc. quarterly revenues are $26.8M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. OraSure Technologies, Inc.'s net income of -$19.3M is lower than Accuray, Inc.'s net income of -$13.8M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.97x versus 0.15x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.97x 26.67x $26.8M -$19.3M ARAYAccuray, Inc.0.15x 149.00x $102.2M -$13.8M
-
Which has Higher Returns OSUR or ATEC?
Alphatec Holdings, Inc. has a net margin of -72.06% compared to OraSure Technologies, Inc.'s net margin of -10.21%. OraSure Technologies, Inc.'s return on equity of -18.18% beat Alphatec Holdings, Inc.'s return on equity of -1092.5%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.40.98% -$0.27 $340.8M ATECAlphatec Holdings, Inc.61.24% -$0.14 $632.1M -
What do Analysts Say About OSUR or ATEC?
OraSure Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 94.81%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 75.7%. Given that OraSure Technologies, Inc. has higher upside potential than Alphatec Holdings, Inc., analysts believe OraSure Technologies, Inc. is more attractive than Alphatec Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is OSUR or ATEC More Risky?
OraSure Technologies, Inc. has a beta of 0.869, which suggesting that the stock is 13.058% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.34%.
-
Which is a Better Dividend Stock OSUR or ATEC?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or ATEC?
OraSure Technologies, Inc. quarterly revenues are $26.8M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $212.9M. OraSure Technologies, Inc.'s net income of -$19.3M is higher than Alphatec Holdings, Inc.'s net income of -$21.7M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.97x versus 2.75x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.97x 26.67x $26.8M -$19.3M ATECAlphatec Holdings, Inc.2.75x -- $212.9M -$21.7M
-
Which has Higher Returns OSUR or BSX?
Boston Scientific Corp. has a net margin of -72.06% compared to OraSure Technologies, Inc.'s net margin of 12.68%. OraSure Technologies, Inc.'s return on equity of -18.18% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.40.98% -$0.27 $340.8M BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About OSUR or BSX?
OraSure Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 94.81%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.75 which suggests that it could grow by 38.28%. Given that OraSure Technologies, Inc. has higher upside potential than Boston Scientific Corp., analysts believe OraSure Technologies, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 BSXBoston Scientific Corp.25 0 0 -
Is OSUR or BSX More Risky?
OraSure Technologies, Inc. has a beta of 0.869, which suggesting that the stock is 13.058% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.
-
Which is a Better Dividend Stock OSUR or BSX?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or BSX?
OraSure Technologies, Inc. quarterly revenues are $26.8M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. OraSure Technologies, Inc.'s net income of -$19.3M is lower than Boston Scientific Corp.'s net income of $670M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Boston Scientific Corp.'s PE ratio is 39.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.97x versus 5.64x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.97x 26.67x $26.8M -$19.3M BSXBoston Scientific Corp.5.64x 39.06x $5.3B $670M
-
Which has Higher Returns OSUR or PSTV?
Plus Therapeutics, Inc. has a net margin of -72.06% compared to OraSure Technologies, Inc.'s net margin of -316.61%. OraSure Technologies, Inc.'s return on equity of -18.18% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital OSUROraSure Technologies, Inc.40.98% -$0.27 $340.8M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About OSUR or PSTV?
OraSure Technologies, Inc. has a consensus price target of $6.00, signalling upside risk potential of 94.81%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1595.96%. Given that Plus Therapeutics, Inc. has higher upside potential than OraSure Technologies, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than OraSure Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OSUROraSure Technologies, Inc.1 2 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is OSUR or PSTV More Risky?
OraSure Technologies, Inc. has a beta of 0.869, which suggesting that the stock is 13.058% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock OSUR or PSTV?
OraSure Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OraSure Technologies, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OSUR or PSTV?
OraSure Technologies, Inc. quarterly revenues are $26.8M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. OraSure Technologies, Inc.'s net income of -$19.3M is lower than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, OraSure Technologies, Inc.'s price-to-earnings ratio is 26.67x while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OraSure Technologies, Inc. is 1.97x versus 5.20x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OSUROraSure Technologies, Inc.1.97x 26.67x $26.8M -$19.3M PSTVPlus Therapeutics, Inc.5.20x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
